| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |